U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900686) titled 'Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival' on March 23.
Brief Summary: This trial is a single-center retrospective study. Eligible patients receiving PD-1 inhibitor treatment will enrolled.
Study Start Date: March 20, 2013
Study Type: OBSERVATIONAL
Condition:
Rectal Cancer
Colon Cancer
Intervention:
DRUG: PD1 Inhibitor
PD1 Inhibitor
Recruitment Status: COMPLETED
Sponsor: Yanhong Deng
Information provided by (Responsible Party): Yanhong Deng, Sun Yat-sen University
Published by HT Digital Content Services with permission from Health Daily Digest....